ACOG
Alpha Cognition Inc.+0.50 (+6.10%) At close · Today 4:00 PM ET
About ACOG
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
Company
- Headquarters
- Grapevine, TX
- Employees
- 71 (2026)
- Listed
- Jun 9, 2021
- Exchange
- Nasdaq
- Website
- alphacognition.com
- SEC industry
- Biological Products, (no Diagnostic Substances)
- Cylvex sector
- Health Care · Biotech
Biotech
- Market cap #84 of 146
- P/B #42 of 131
Ranked highest first among stocks Cylvex covers.
- AMGNAmgen Inc$258.6B+3.72%
- GILDGilead Sciences Inc$216.4B+4.18%
- MRNAModerna Inc$103.1B+13.10%
- ARGXargenx SE$58.57B+3.36%
- RVMDRevolution Medicines, Inc.$42.77B+2.74%
Financial summary
Related companies
About
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
From company filings and market data · Not investment advice
Price data
From daily bars
Financials
Consensus estimates
The information provided is for educational purposes only and does not constitute investment advice. Past performance does not guarantee future results.